TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Axsome Therapeutics Inc (AXSM)

Healthcare Biotechnology
211.00 $
-3.2% vs. previous close
Closing price · As of: 3. Aug 2026

Axsome Therapeutics Inc (AXSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 714 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet AXSM
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
612 601 588 546 548 561 568 597 640 669 690 714
520 512 504 460 463 479 485 495 537 565 589 611
437 417 386 331 316 327 315 301 303 325 323 305
437 417 386 331 316 327 315 301 303 325 323 305
67 78 95 101 120 124 142 161 199 197 224 251
9.3 10.0 15 16 15 14 16 16 18 24 28 32
16 8.0 – – – – – – – – – –
12 12 12 12 12 12 12 12 12 12 12 12
57 55 53 52 50 49 47 45 44 42 41 39
333 331 397 402 445 469 511 543 567 596 602 659
115 115 139 144 187 196 230 244 342 360 379 439
0.4 0.4 1.3 1.8 2.6 2.9 3.3 2.3 72 73 73 74
43 29 41 54 61 64 72 86 92 54 66 107
177 177 178 179 179 180 181 181 118 118 118 118
279 270 191 144 103 93 57 53 73 74 88 55
-675 -737 -836 -904 -983 -1,048 -1,123 -1,182 -1,230 -1,277 -1,306 -1,371
44 47 47 47 48 48 49 49 49 50 51 51

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?